Background There is conflicting evidence regarding the effect of asthma and its different
therapeutic options on COVID-19 severity and the clinical outcomes. Aim This study aimed …

Background: The impact of inhaled corticosteroid (ICS) in the interaction between asthma,
COVID-19 and COVID-19 associated outcomes remain largely unknown. The objective of …

Background An association between the severity of coronavirus disease 2019 (COVID-19)
and the presence of certain chronic conditions has been suggested. However, unlike …

Purpose It is unclear whether asthma is a risk factor for the development of COVID-19;
however, severe asthma is a risk factor for morbidity and mortality. While systemic …

Background: The comorbidities and clinical signs of coronavirus disease 2019 (COVID-19)
patients have been reported mainly as descriptive statistics, rather than quantitative analysis …

Background Inhaled corticosteroids have been widely reported as a preventive measure
against the development of severe forms of COVID-19 not only in patients with asthma …

Abstract Coronavirus disease 2019 (COVID-19) continues to spread across the world. Since
the beginning of the pandemic, the question of whether asthma is a risk factor for getting the …

Background: Spain has been severely affected by the COVID-19 epidemic, with 195,944
persons infected and 20,453 deaths at the time of writing. Older people with respiratory or …

Objective: With emerging of observational evidence, we aimed to perform a meta-analysis to
summarize the overall effect of the chronic use of inhaled corticosteroids on the clinical …

Background WHO quoted the numbers for the Coronavirus disease 2019 (COVID-19)
pandemic as of August 2021 were 200 million cases with over 4 million deaths globally …